Showing 1 - 7 results of 7 for search 'Agnes Schwieger-Briel', query time: 0.03s Refine Results
  1. 1
    Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study

    Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study by Agnes Schwieger-Briel, Dimitra Kiritsi, Christoph Schempp, Cristina Has, Hauke Schumann

    Published 2017-01-01
    Get full text
    Article
  2. 2
    Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

    Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale by Johannes S. Kern, Agnes Schwieger-Briel, Sandra Löwe, Mark Sumeray, Charles Davis, Anna E. Martinez

    Published 2019-06-01
    Get full text
    Article
  3. 3
    Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts

    Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts by Sarah Ventéjou, Agnes Schwieger-Briel, Rebecca Nicolai, Stephanie Christen-Zaech, Caroline Schnider, Michael Hofer, Sofia Bogiatzi, Daniel Hohl, Fabrizio De Benedetti, Marie-Anne Morren

    Published 2021-03-01
    Get full text
    Article
  4. 4
    EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

    EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa by Andrea Diociaiuti, Holger Steinke, Alexander Nyström, Agnes Schwieger-Briel, Frank Meiss, Christina Pfannenberg, Leena Bruckner-Tuderman, Juri Ruf, Rita De Vito, May El Hachem, Dimitra Kiritsi

    Published 2019-12-01
    Get full text
    Article
  5. 5
    Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trialResearch in context

    Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trialResearch in context by Dimitra Kiritsi, Franziska Schauer, Stella Gewert, Katja Reineker, Antonia Reimer-Taschenbrecker, Agnes Schwieger-Briel, Hagen Ott, Claudia Schmoor, Olga Grishina, Dedee Murrell, Brigitte Stiller, Tobias Zahn, Alexander Nyström, Leena Bruckner-Tuderman

    Published 2024-11-01
    Get full text
    Article
  6. 6
    Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa

    Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa by Carmen Liy-Wong, Cristina Tarango, Elena Pope, Thomas Coates, Anna L. Bruckner, James A. Feinstein, Agnes Schwieger-Briel, Lynne D. Hubbard, Clapham Jane, Mauricio Torres-Pradilla, Matija Zmazek, Irene Lara-Corrales

    Published 2023-02-01
    Get full text
    Article
  7. 7
    Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negative T-Lymphocytes

    Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negati... by Seraina Prader, Matthias Felber, Matthias Felber, Benjamin Volkmer, Johannes Trück, Agnes Schwieger-Briel, Martin Theiler, Martin Theiler, Lisa Weibel, Lisa Weibel, Sophie Hambleton, Katja Seipel, Stefano Vavassori, Jana Pachlopnik Schmid, Jana Pachlopnik Schmid

    Published 2018-12-01
    Get full text
    Article

Search Tools: